Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00246_DB01195_nanopub.RAKHYBPzOxz3DCL-b_aJOl-rCV9KZvTEY9FLfuo3ATU64#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00246_DB01195 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00246_DB01195 label "DDI between Ziprasidone and Flecainide - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated. [drugbank_resource:DB00246_DB01195]" assertion.
- drugbank_resource:DB00246_DB01195 identifier "drugbank_resource:DB00246_DB01195" assertion.
- drugbank_resource:DB00246_DB01195 title "DDI between Ziprasidone and Flecainide - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00246 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00246_DB01195 assertion.
- drugbank:DB01195 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00246_DB01195 assertion.